TET2 mutations in acute myeloid leukemia: a comprehensive study in patients of Sindh, Pakistan.
Abdul Rehman Khalil ShaikhIkram UjjanMuhammad IrfanArshi NazTahir Sultan ShamsiMuhammad Tariq Masood KhanMuhammad ShakeelPublished in: PeerJ (2021)
TET2 mutations were identified in around 16% of the total patients of our study indicating other mechanisms being involved in pathophysiology of AML in this cohort. The TET2 mutations provide a prognostic value in determining AML classification.